Denali Therapeutics shares owned by Baillie Gifford & Co
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Baillie Gifford & Co
from 13F filings
Historical chart of Baillie Gifford & Co investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Baillie Gifford & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Baillie Gifford & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $168M | 12M | 14.52 |
| 2025-06-30 | $167M | 12M | 13.99 |
| 2025-03-31 | $164M | 12M | 13.60 |
| 2024-12-31 | $251M | 12M | 20.38 |
| 2024-09-30 | $389M | 13M | 29.13 |
| 2024-06-30 | $320M | 14M | 23.22 |
| 2024-03-31 | $288M | 14M | 20.52 |
| 2023-12-31 | $306M | 14M | 21.46 |
| 2023-09-30 | $303M | 15M | 20.63 |
| 2023-06-30 | $438M | 15M | 29.51 |
| 2023-03-31 | $354M | 15M | 23.04 |
| 2022-12-31 | $421M | 15M | 27.81 |
| 2022-09-30 | $452M | 15M | 30.69 |
| 2022-06-30 | $438M | 15M | 29.43 |
| 2022-03-31 | $482M | 15M | 32.17 |
| 2021-12-31 | $672M | 15M | 44.60 |
| 2021-09-30 | $757M | 15M | 50.45 |
| 2021-06-30 | $1.2B | 15M | 78.44 |
| 2021-03-31 | $742M | 13M | 57.10 |
| 2020-12-31 | $1.0B | 12M | 83.76 |
| 2020-09-30 | $388M | 11M | 35.83 |
| 2020-06-30 | $224M | 9.3M | 24.18 |
| 2020-03-31 | $160M | 9.1M | 17.51 |
| 2019-12-31 | $132M | 7.6M | 17.42 |
| 2019-09-30 | $113M | 7.4M | 15.32 |
| 2019-06-30 | $154M | 7.4M | 20.76 |
| 2019-03-31 | $145M | 6.3M | 23.19 |
| 2018-12-31 | $129M | 6.2M | 20.66 |
| 2018-09-30 | $119M | 5.5M | 21.74 |
| 2018-06-30 | $82M | 5.3M | 15.25 |
| 2018-03-31 | $102M | 5.2M | 19.69 |
| 2017-12-31 | $77M | 4.9M | 15.64 |